Humer Franz B

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Humer Franz B's trades of Allogene Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
85.56
Quantity 80,664
Value US$3,328,942
Transaction date
Proposed sale
Price
15.55
Quantity 18,491
Value US$4,185,766
Transaction date
Proposed sale
Price
2.47
Quantity 11,200
Value US$27,716
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-04 2024-12-06
PrS Proposed sale
80,664
85.56
US$3,328,942 		80,664 85.56 US$3,328,942
2024-12-09 2024-12-05
S Sale
97,317 -14.4%
383.86
US$799,428 		97,317 -14.4% 383.86 US$799,428
2024-12-02 2024-12-03
PrS Proposed sale
18,491
15.55
US$4,185,766 		18,491 15.55 US$4,185,766
2024-06-03 2024-05-30
S Sale
11,200 -4.2%
2.34
US$26,181 		11,200 -4.2% 2.34 US$26,181
2024-05-29 2024-05-29
PrS Proposed sale
11,200
2.47
US$27,716 		11,200 2.47 US$27,716